Press Releases October 1, 2026 08:01 AM

Global-e Appoints Tomer Gold as Chief Revenue Officer

Global-e appoints Tomer Gold as new Chief Revenue Officer to lead growth

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
GLBE

Global-e Online Ltd., a leading global e-commerce platform, announced that Tomer Gold, previously Executive Vice President of SMB & Channel division, will become Chief Revenue Officer effective October 1, 2026. The outgoing CRO, Ran Fridman, is departing after over five years of service. The company expects Gold's leadership to support the next phase of growth in its global commercial organization.

Global-e Appoints Tomer Gold as Chief Revenue Officer
GLBE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Tomer Gold promoted to Chief Revenue Officer, indicating a leadership transition in Global-e's commercial operations.
  • Ran Fridman, the outgoing CRO, leaves after enhancing the company’s global growth and commercial scaling.
  • Global-e continues to focus on expanding its international e-commerce platform, serving over 1,500 brands across multiple regions including North America, EMEA, and APAC.

PETAH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE), the leading global e-commerce enablement platform powering the world's most iconic brands, today announced that Tomer Gold, currently Executive Vice President of the company's SMB & Channel division, will become Chief Revenue Officer, effective October 1, 2026. Gold brings extensive experience across Global-e's commercial organization and a deep understanding of its customers, products, and global growth strategy. He will lead the company's revenue organization as Global-e enters its next phase of growth.

Ran Fridman, Chief Revenue Officer, will leave the company after more than five years to pursue his next opportunity. During his tenure, Fridman helped scale the company's commercial organization and supported its growth worldwide.

"As our first ever hired CRO, Ran played a pivotal role in scaling Global-e's business and global outreach. We thank him for his valuable contribution to the company's growth, and wish him great success in his new endeavor," said Nir Debbi, President of Global-e. "We also wish Tomer much success in his new role as CRO. Given Tomer's proven leadership abilities and his in-depth knowledge of Global-e's organization and business lines, we are confident he will lead the company's commercial organization to new heights."

About Global-e

Global-e (Nasdaq: GLBE) is the world's leading platform enabling and accelerating global, Direct-To-Consumer e-commerce. The chosen partner of over 1,500 brands and retailers across North America, EMEA and APAC, Global-e makes selling internationally as simple as selling domestically. The company enables merchants to increase the conversion of international traffic into sales by offering online shoppers in over 200 destinations worldwide a seamless, localized shopping experience. Global-e's end-to-end e-commerce solutions combine best-in-class localization capabilities, big-data best-practice business intelligence models, streamlined international logistics and vast global e-commerce experience, enabling international shoppers to buy seamlessly online and retailers to sell to, and from, anywhere in the world. For more information, please visit: www.global-e.com.

Investor Contact:
Alan Katz
Global-e Investor Relations
[email protected]

Press Contact:
Sarah Small
Headline Media
[email protected] 
+1 (914) 336-4718


Risks

  • Uncertainty in leadership transition effect on sustaining growth momentum globally.
  • Competition in the global e-commerce enablement sector could impact market share expansion.
  • Dependence on continued international trade dynamics and cross-border e-commerce regulations, which can affect operational efficiency.

More from Press Releases

Silvaco CEO Dr. Walden “Wally” Rhines Inducted into the National Academy of Engineering Oct 2, 2026 Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A) Oct 2, 2026 Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 Oct 1, 2026 New Drug Application Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA Real-Time Oncology Review Program Oct 1, 2026 FEMSA Schedules Conference Call to Discuss Third Quarter Financial Results Oct 1, 2026